methylene blue/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases incidence of postoperative delirium
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“A total of 55 patients (17.5%) experienced POD, with a lower POD incidence in the methylene blue group than in the control group (11.5% vs. 23.6%, p = 0.005).”
Quoted verbatim from Intraoperative methylene blue infusion reduces postoperative delirium in patients undergoing pancreatic surgery: A randomized controlled clinical trial.. - Study
- RCT
- Dose
- methylene blue 2 mg/kg IV within 60 min after anesthetic induction, followed by 1 mg/kg IV within 30 min before end of surgery
- Population
- adult patients undergoing pancreatic surgery
Intraoperative methylene blue infusion reduces postoperative delirium in patients undergoing pancreatic surgery: A randomized controlled clinical trial.2025PMID:41176956Permalink
Keep reading
- Everything the graph holds on methylene blue
- Every compound studied against Incidence of postoperative delirium
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1Z4TB9EJWZANW417NXX142B